Circulating tenascin-C levels predict renal progression in type 2 diabetes

被引:0
|
作者
Lui, D. T. W. [1 ]
Lee, C. [1 ]
Cheung, C. Y. Y. [1 ]
Fong, C. H. Y. [1 ]
Chow, W. [1 ]
Woo, Y. [1 ]
Lam, K. S. L. [1 ]
机构
[1] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
132
引用
收藏
页码:71 / 71
页数:1
相关论文
共 50 条
  • [41] Pressure Overload-induced Right Ventricular Failure is Associated with Re-expression of Myocardial Tenascin-C and Elevated Plasma Tenascin-C Levels
    Hessel, Marleen
    Steendijk, Paul
    den Adel, Brigit
    Schutte, Cindy
    van der Laarse, Arnoud
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2009, 24 (3-4) : 201 - 210
  • [42] Tenascin-C concentration in synovial fluid correlates with radiographic progression of knee osteoarthritis
    Hasegawa, M
    Hirata, H
    Sudo, A
    Kato, K
    Kawase, D
    Kinoshita, N
    Yoshida, T
    Uchida, A
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (10) : 2021 - 2026
  • [43] Clinical impact and functional aspects of tenascin-C expression during glioma progression
    Herold-Mende, C
    Mueller, MM
    Bonsanto, MM
    Schmitt, HP
    Kunze, S
    Steiner, HH
    INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (03) : 362 - 369
  • [44] Serum tenascin-c levels might be a candidate biomarker for myocardial noncompaction
    Erer, H. B.
    Guvenc, T. S.
    Kemik, A.
    Altay, S.
    Sayar, N.
    Oz, D.
    Ekmekei, A.
    Zeneirei, A.
    Kul, S.
    Eren, M.
    EUROPEAN HEART JOURNAL, 2012, 33 : 28 - 28
  • [45] HIGH CIRCULATING LEVELS OF TENASCIN-C WERE ASSOCIATED WITH CORONARY ARTERIAL CALCIFICATION IN PATIENTS WITH STABLE EFFORT ANGINA PECTORIS
    Nobuo, Sakamoto
    Nakazato, Kazuhiko
    Kunii, Hiroyuki
    Misaka, Tomofumi
    Mizukami, Hiroyuki
    Sugimoto, Koichi
    Saitoh, Shu-ichi
    Ishibashi, Toshiyuki
    Takeishi, Yasuchika
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [46] Pressure overload-induced right ventricular dilatation is associated with re-expression of myocardial tenascin-C and increased plasma levels of tenascin-C
    Hessel, M. H. M.
    Steendijk, P.
    den Adel, B.
    Schutte, C. I.
    van der Laarse, A.
    CIRCULATION, 2006, 114 (18) : 133 - 133
  • [47] Assessment of circulating fibrotic proteins (periostin and tenascin -C) In Type 2 diabetes mellitus patients with and without retinopathy
    A. Indumathi
    Gandhipuram Periyaswamy Senthilkumar
    Kuppuswamy Jayashree
    K. Ramesh Babu
    Endocrine, 2022, 76 : 570 - 577
  • [48] Assessment of circulating fibrotic proteins (periostin and tenascin -C) In Type 2 diabetes mellitus patients with and without retinopathy
    Indumathi, A.
    Senthilkumar, Gandhipuram Periyaswamy
    Jayashree, Kuppuswamy
    Babu, K. Ramesh
    ENDOCRINE, 2022, 76 (03) : 570 - 577
  • [49] Do the levels of hepcidin and tenascin-C change in patients with preterm premature rupture of membranes? Can these markers help in diagnosis? Hepcidin and tenascin-C levels in preterm premature rupture of membranes
    Ildogan, Betul Tuncer
    Ercan, Fedi
    Saglam, Ceren
    Purut, Yunus Emre
    Kaya, Firat
    Karaaslan, Onur
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2023, 14 : 270 - 273
  • [50] Novel Circulating Biomarkers Predict Rapidly Declining Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study
    Peters, Kirsten E.
    Davis, Wendy A.
    Ito, Jun
    Winfield, Kaye
    Stoll, Thomas
    Bringans, Scott D.
    Lipscombe, Richard J.
    Davis, Timothy M. E.
    DIABETES, 2017, 66 : LB5 - LB5